https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-02-20 / Front Immunol 2024;15:1368103
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-02-20 / Front Immunol 2024;15:13681032024-02-20 00:00:002024-02-20 00:00:00Dendritic cell vaccination combined with carboplatin/paclitaxel for metastatic endometrial cancer patients: results of a phase I/II trial
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-02-10 / J Med Case Rep 2024 Feb;18(1):88
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-02-10 / J Med Case Rep 2024 Feb;18(1):882024-02-10 00:00:002024-02-10 00:00:00Dendritic cell vaccination in combination with erlotinib in a patient with inoperable lung adenocarcinoma: a case report
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-02-01 / Cancer Lett 2024 Mar;585:216634
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-02-01 / Cancer Lett 2024 Mar;585:2166342024-02-01 00:00:002024-02-01 00:00:00Oncolytic virus-based combination therapy in breast cancer
